Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S18B pseudogene 1 (MRPS18BP1) is a processed pseudogene sequence in the human genome[2][4][5]. It is derived from the mitochondrial ribosomal protein S18B gene, but does not encode a functional protein and has no documented biological activity. Pseudogenes like MRPS18BP1 typically arise due to duplication or retrotransposition events and are generally transcriptionally inactive; they do not participate in ribosomal or mitochondrial function. MRPS18BP1 has no recognized role in disease, drug interactions, or as a therapeutic target. It is included in genomic databases for reference and annotation purposes, not for functional or translational research[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S18B pseudogene 1 (MRPS18BP1).